COVID-19 hospitalizations in Michigan have been rising in recent weeks, with 875 adults hospitalized with confirmed or suspected cases on May 11; 77 of that number were in intensive care units. In addition, 36 children were in the hospital with confirmed or suspected cases on that date. A daily average of over 2,700 cases were confirmed from May 5 through 11.
MDHHS Shares Updated FDA Guidelines for Johnson & Johnson COVID-19 Vaccine
The Michigan Department of Health and Human Services (MDHHS) has reminded providers of updated guidelines from the Food and Drug Administration (FDA) for use of the Johnson & Johnson/Janssen COVID-19 vaccine. The new guidelines essentially limit use to individuals 18 and older who cannot or will not take one of the other approved vaccines. The risk of thrombosis with thrombocytopenia syndrome (TTS) warrants limiting the authorized use of the vaccine. TTS is a syndrome of rare and potentially life-threatening blood clots in combination with low levels of blood platelets. Members are encouraged to review the provider guidelines. For more information regarding vaccines, contact Ruthanne Sudderth at the MHA.
Additional information on the COVID-19 pandemic is available to members on the MHA Community Site and the MHA COVID-19 webpage. Questions on COVID-19 and infectious disease response strategies may be directed to the MDHHS Community Health Emergency Coordination Center (CHECC).